Twist Bioscience (TWST) Competitors $38.03 -0.44 (-1.14%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$37.65 -0.38 (-1.00%) As of 07/11/2025 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TWST vs. ADPT, BEAM, CRSP, TXG, VCYT, DNA, BPMC, BBIO, VRNA, and ROIVShould you be buying Twist Bioscience stock or one of its competitors? The main competitors of Twist Bioscience include Adaptive Biotechnologies (ADPT), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), 10x Genomics (TXG), Veracyte (VCYT), Ginkgo Bioworks (DNA), Blueprint Medicines (BPMC), BridgeBio Pharma (BBIO), Verona Pharma PLC American Depositary Share (VRNA), and Roivant Sciences (ROIV). These companies are all part of the "medical" sector. Twist Bioscience vs. Its Competitors Adaptive Biotechnologies Beam Therapeutics CRISPR Therapeutics 10x Genomics Veracyte Ginkgo Bioworks Blueprint Medicines BridgeBio Pharma Verona Pharma PLC American Depositary Share Roivant Sciences Adaptive Biotechnologies (NASDAQ:ADPT) and Twist Bioscience (NASDAQ:TWST) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations. Which has more volatility & risk, ADPT or TWST? Adaptive Biotechnologies has a beta of 1.83, meaning that its share price is 83% more volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 2.41, meaning that its share price is 141% more volatile than the S&P 500. Do institutionals and insiders have more ownership in ADPT or TWST? 99.2% of Adaptive Biotechnologies shares are owned by institutional investors. 6.4% of Adaptive Biotechnologies shares are owned by company insiders. Comparatively, 3.0% of Twist Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media prefer ADPT or TWST? In the previous week, Adaptive Biotechnologies had 4 more articles in the media than Twist Bioscience. MarketBeat recorded 13 mentions for Adaptive Biotechnologies and 9 mentions for Twist Bioscience. Twist Bioscience's average media sentiment score of 0.60 beat Adaptive Biotechnologies' score of 0.51 indicating that Twist Bioscience is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adaptive Biotechnologies 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Twist Bioscience 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings and valuation, ADPT or TWST? Adaptive Biotechnologies has higher earnings, but lower revenue than Twist Bioscience. Adaptive Biotechnologies is trading at a lower price-to-earnings ratio than Twist Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptive Biotechnologies$189.53M9.47-$159.49M-$0.96-12.31Twist Bioscience$347.68M6.55-$208.73M-$3.25-11.70 Do analysts rate ADPT or TWST? Adaptive Biotechnologies currently has a consensus target price of $10.57, suggesting a potential downside of 10.56%. Twist Bioscience has a consensus target price of $50.40, suggesting a potential upside of 32.53%. Given Twist Bioscience's higher possible upside, analysts clearly believe Twist Bioscience is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adaptive Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70 Is ADPT or TWST more profitable? Twist Bioscience has a net margin of -54.98% compared to Adaptive Biotechnologies' net margin of -74.84%. Twist Bioscience's return on equity of -33.48% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Adaptive Biotechnologies-74.84% -62.79% -24.55% Twist Bioscience -54.98%-33.48%-25.34% SummaryAdaptive Biotechnologies and Twist Bioscience tied by winning 8 of the 16 factors compared between the two stocks. Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TWST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TWST vs. The Competition Export to ExcelMetricTwist BioscienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.28B$2.94B$5.56B$9.11BDividend YieldN/A2.42%5.06%4.01%P/E Ratio-11.7020.8528.2620.26Price / Sales6.55303.05437.10166.10Price / CashN/A42.1137.1257.67Price / Book4.717.638.045.49Net Income-$208.73M-$55.05M$3.19B$250.45M7 Day Performance-0.21%8.43%3.62%4.79%1 Month Performance13.45%8.14%5.98%9.59%1 Year Performance-28.84%1.62%29.39%16.41% Twist Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TWSTTwist Bioscience4.3885 of 5 stars$38.03-1.1%$50.40+32.5%-28.8%$2.28B$347.68M-11.70990Gap DownADPTAdaptive Biotechnologies2.8825 of 5 stars$11.74-0.5%$10.57-10.0%+195.5%$1.78B$178.96M-12.23790BEAMBeam Therapeutics2.0931 of 5 stars$19.18-4.1%$48.75+154.2%-21.3%$1.93B$63.52M-4.16510News CoverageCRSPCRISPR Therapeutics3.2427 of 5 stars$51.19-1.9%$71.75+40.2%-1.9%$4.42B$37.31M-11.33460News CoverageAnalyst ForecastOptions VolumeTXG10x Genomics4.5129 of 5 stars$11.92-8.4%$14.96+25.5%-26.8%$1.47B$624.66M-9.171,240VCYTVeracyte3.5949 of 5 stars$26.34-4.3%$40.90+55.3%+19.0%$2.06B$445.76M64.25790DNAGinkgo Bioworks0.7876 of 5 stars$11.38-10.5%$5.77-49.3%N/A$666.09M$237.42M-1.24640News CoverageGap DownBPMCBlueprint Medicines1.2222 of 5 stars$128.40+0.0%$128.06-0.3%+9.8%$8.29B$508.82M-51.98640Insider TradeBBIOBridgeBio Pharma4.6657 of 5 stars$43.50-1.1%$58.85+35.3%+71.3%$8.26B$221.90M-12.32400Analyst UpgradeVRNAVerona Pharma PLC American Depositary Share2.3793 of 5 stars$91.20-0.4%$107.36+17.7%+403.5%$7.76B$42.28M-45.6030Trending NewsAnalyst ForecastROIVRoivant Sciences3.0006 of 5 stars$10.74-2.3%$17.50+62.9%+0.1%$7.30B$29.05M-42.96860News CoverageAnalyst Upgrade Related Companies and Tools Related Companies Adaptive Biotechnologies Alternatives Beam Therapeutics Alternatives CRISPR Therapeutics Alternatives 10x Genomics Alternatives Veracyte Alternatives Ginkgo Bioworks Alternatives Blueprint Medicines Alternatives BridgeBio Pharma Alternatives Verona Pharma PLC American Depositary Share Alternatives Roivant Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TWST) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
